Jade Biosciences

(NASDAQ) JBIO

Current Price$22.37

Market Cap$1.30B

Since IPO (2025)+161%

5 YearN/A

1 Year+170%

1 Month+98%

Jade Biosciences Financials at a Glance

Market Cap

$1.30B

Revenue (TTM)

$0.00

Net Income (TTM)

$127.41M

EPS (TTM)

$-5.45

P/E Ratio

-4.85

Dividend

$0.00

Beta (Volatility)

0.15 (Low)

Dividend

$0.00

Beta (Volatility)

0.15 (Low)

Price

$22.37

Volume

1,195,826

Open

$26.26

Price

$22.37

Volume

1,195,826

Open

$26.26

Previous Close

$22.32

Daily Range

$22.29 - $26.26

52-Week Range

$6.57 - $28.00

Dividend

$0.00

Beta (Volatility)

0.15 (Low)

Price

$22.37

Volume

1,195,826

Open

$26.26

Previous Close

$22.32

Daily Range

$22.29 - $26.26

52-Week Range

$6.57 - $28.00

JBIO News

Jade Biosciences Posts Wider Loss in Q2

Motley Fool Markets TeamAug 13, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Jade Biosciences

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Tom Frohlich, MBA

Website

www.jadebiosciences.com

Headquarters

Waltham, MA 02453, US

JBIO Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-45%

Return on Capital

-28%

Return on Assets

-36%

Earnings Yield

-20.62%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.30B

Shares Outstanding

49.32M

Volume

1.20M

Avg. Volume

491.53K

Financials (TTM)

Gross Profit

$26.00K

Operating Income

$113.54M

EBITDA

$113.54M

Operating Cash Flow

$94.69M

Capital Expenditure

$196.00K

Free Cash Flow

$94.89M

Cash & ST Invst.

$336.16M

Total Debt

$724.00K

Jade Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$9.00K

-12.5%

Gross Margin

0.00%

N/A

Market Cap

$1.30B

N/A

Market Cap/Employee

$26.09M

N/A

Employees

N/A

Net Income

$67.58M

-1144.6%

EBITDA

$34.90M

-550.3%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$335.43M

+328.9%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$724.00K

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-36.43%

N/A

Return on Invested Capital

-28.07%

N/A

Free Cash Flow

$33.65M

-190.2%

Operating Cash Flow

$33.65M

-190.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TECXTectonic Therapeutic, Inc.

TECXTectonic Therapeutic, Inc.$27.07-0.48%

XOMAXOMA Royalty Corp.

XOMAXOMA Royalty Corp.$40.99+0.32%

LYELLyell Immunopharma, Inc.

LYELLyell Immunopharma, Inc.$20.60-4.54%

CTNMContineum Therapeutics, Inc. Class A Common Stock

CTNMContineum Therapeutics, Inc. Class A Common Stock$12.04-3.99%

KYTXKyverna Therapeutics, Inc.

KYTXKyverna Therapeutics, Inc.$8.40-3.45%

SLNSilence Therapeutics plc

SLNSilence Therapeutics plc$7.11-7.84%

ACIUAC Immune S.A.

ACIUAC Immune S.A.$2.93-3.30%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$94.75+0.12%

SOFISoFi Technologies

SOFISoFi Technologies$15.53-0.15%

NOKNokia

NOKNokia$12.46+0.10%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.14+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$61.86+0.02%

POETPoet Technologies

POETPoet Technologies$6.60-0.18%

ONDSOndas

ONDSOndas$9.49-0.09%

Questions About JBIO

What is the current price of Jade Biosciences?

Jade Biosciences is trading at $22.32 per share.

What is the 52-week range for Jade Biosciences?

Over the past 52 weeks, Jade Biosciences has traded between $6.57 and $28.00.

How much debt does Jade Biosciences have?

As of the most recent reporting period, Jade Biosciences reported total debt of $724,000.

How much cash does Jade Biosciences have on hand?

Jade Biosciences reported $88.44M in cash and cash equivalents in its most recent financial results.

What is Jade Biosciences’s dividend yield?

Jade Biosciences does not currently have a dividend yield.

Jade Biosciences

Jade Biosciences Financials at a Glance

JBIO News

Jade Biosciences Posts Wider Loss in Q2

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Jade Biosciences

JBIO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Jade Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About JBIO

What is the current price of Jade Biosciences?

What is the 52-week range for Jade Biosciences?

How much debt does Jade Biosciences have?

How much cash does Jade Biosciences have on hand?

What is Jade Biosciences’s dividend yield?

Premium Investing Services